Syquant Capital’s Apollo Endosurgery APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-300,000
Closed -$2.98M – 16
2023
Q1
$2.98M Buy
+300,000
New +$2.97M 6.9% 4

Syquant Capital's APEN Position: Q2 2023 in Review

Syquant Capital sold out of Apollo Endosurgery (APEN) in Q2 2023, closing a stake of 300,000 shares — an estimated $2.98M sold.

Syquant Capital first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $2.98M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Syquant Capital reported no remaining Apollo Endosurgery position as of Q2 2023 after selling out during the quarter.
  • Syquant Capital sold 300,000 Apollo Endosurgery shares in Q2 2023, an estimated $2.98M.
  • Syquant Capital first reported a position in Apollo Endosurgery in Q1 2023 and held it in 1 quarter.
  • Syquant Capital's Apollo Endosurgery position peaked at $2.98M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery as of Q2 2023.

Based on Syquant Capital's 13F filing for Q2 2023, filed 10 Jul 2023.